SCHEMBL22016090

SCHEMBL22016090

Bn1ccc(N)nc1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4492972 0.79
SCHEMBL25378286 0.76
SCHEMBL11894064 0.76
SCHEMBL27667318 0.76 PDE3A (0.39)
SCHEMBL48395 0.74
SCHEMBL5985575 0.74
SCHEMBL7876669 0.74
SCHEMBL19692381 0.74
SCHEMBL4726442 0.74
SCHEMBL27603451 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4283346-A1 OPTICAL FILM AND DISPLAY DEVICE TOPPAN INC. (JP) 2023-11-29 EP disclosed
EP-4194493-A1 CITRATE-BASED PLASTICIZER COMPOSITION AND RESIN COMPOSITION COMPRISING SAME Lg Chem, Ltd. (KR) 2023-06-14 EP disclosed
WO-2023086978-A2 BRANCHED TRIPLE LIPID-MODIFIED NUCLEIC ACID COMPOUNDS DTX PHARMA, INC. (US) 2023-05-19 WO disclosed
US-11633528-B2 Apparatus for removing chemotherapy compounds from blood DELCATH SYSTEMS, INC. (US) 2023-04-25 US disclosed
WO-2022081920-A1 SYSTEMS FOR AND METHODS OF TREATMENT SELECTION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-04-21 WO disclosed
WO-2020099652-A1 COMPOUNDS THAT SELECTIVELY AND EFFECTIVELY INHIBIT HAKAI-MEDIATED UBIQUITINATION, AS ANTI-CANCER DRUGS FUNDACIÓN PROFESOR NOVOA SANTOS (ES) 2020-05-22 WO disclosed